DCF — ARTHUR G JAMES CANCER HOSPITAL
Enterprise Value: $1.2B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$1.2B
Enterprise Value
$315.9M
PV of Cash Flows
$925.2M
PV of Terminal Value
$1.5B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $2.0B | $170.5M | 9.0% | $55.5M | $50.5M |
| Year 2 | $2.1B | $196.3M | 10.0% | $72.7M | $60.0M |
| Year 3 | $2.1B | $223.4M | 11.0% | $90.8M | $68.2M |
| Year 4 | $2.2B | $241.1M | 11.0% | $101.7M | $69.5M |
| Year 5 | $2.3B | $254.0M | 11.0% | $109.0M | $67.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $1.2B. Terminal value accounts for 75% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$1.9B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.08000000022594927
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5